American Gene Technologies gets US FDA nod for Phase 1 clinical trial of potential HIV cure
AGT’s Phase 1 trial will investigate the safety of AGT103-T, a single-dose, lentiviral vector-based gene therapy, and measure key…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.